Barclays
QGENF

Barclays’s QIAGEN NV QGENF Stock Holding History

Barclays’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,100
Closed -$552K – 7165
2016
Q3 		$552K Buy
+20,100
New +$552K ﹤0.01% 3131

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Barclays's QGENF Position: Q1 2017 in Review

Barclays sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 195,575 shares — an estimated $5.48M sold.

Barclays first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $22.2M in Q1 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Barclays reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Barclays sold 195,575 QIAGEN NV shares in Q1 2017, an estimated $5.48M.
  • Barclays first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • Barclays's QIAGEN NV position peaked at $22.2M in Q1 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.